US President’s latest tariff move will see the US impose 100% levies on imports of branded or patented pharmaceutical goods from October 1. What could it mean for global trade? The decision is part of a broader strategy to protect domestic industries and reduce reliance on foreign suppliers. However, experts warn that such high tariffs could lead to retaliatory measures from trading partners and disrupt global supply chains.